CD8A and nonpapillary renal cell carcinoma: Thus, besides the well-known role of PD-1 blockade on cytotoxic CD8+ T cells, our results suggest that NK cells might also be involved in the efficacy of anti-PD-1/PD-L1 immunotherapy in ccRCC.